中国处方药2024,Vol.22Issue(1) :55-59.

静脉药物配置中心不合理用药的分析

Analysis of unreasonable drug use in Pharmacy intravenous admixture service

严烨
中国处方药2024,Vol.22Issue(1) :55-59.

静脉药物配置中心不合理用药的分析

Analysis of unreasonable drug use in Pharmacy intravenous admixture service

严烨1
扫码查看

作者信息

  • 1. 余姚市人民医院,浙江余姚 315400
  • 折叠

摘要

目的 对静脉用药不合理医嘱进行分析,为提高临床静脉用药的合理性提供依据,确保用药的安全性.方法 选取静脉药物配置中心(PIVAS)2022 年 1~12 月审方药师干预的不合理医嘱,并进行分析.结果 2022 年 1~12 月PIVAS不合理医嘱共计 1 899 例,涉及溶媒种类和用量、配伍禁忌、药物用法用量、给药途径、全肠外营养液(TPN)组分等问题.结论 PIVAS审方药师对不合理用药的医嘱能够有效干预,确保患者的用药安全,达到有效治疗的目的.

Abstract

Objective To analyze the unreasonable medical orders of intravenous medication,in order to provide a basis for improving the rationality of clinical intravenous medication and ensuring the safety of the medication.Methods Select and analyze unreasonable medical orders in Pharmacy intravenous admixture service intervened by prescription-checking pharmacists from January to December 2022.Results From January to December 2022,there were 1 899 cases of unreasonable medical orders in PIVAS,involving the types and dosage of solvents,incompatibilities,usage and dosage of drugs,route of administration,composition of TPN,etc.Conclusion Prescription-checking pharmacists of PIVAS can effectively intervene in unreasonable medication orders,ensure patient medication safety,and achieve the goal of effective treatment.

关键词

静脉药物配置中心/不合理医嘱/分析

Key words

Pharmacy intravenous admixture service/Unreasonable medical orders/Analysis

引用本文复制引用

出版年

2024
中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
参考文献量17
段落导航相关论文